

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.54055633 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.39464102 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.39464102 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.28636114 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.96039572 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 4.80429951 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 4.71896669 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.51229150 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.47191250 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.41596452 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.41596452 |
| 12 | B cell receptor signaling pathway (GO:0050853) | 4.38541050 |
| 13 | negative T cell selection (GO:0043383) | 4.38522013 |
| 14 | negative regulation of T cell mediated immunity (GO:0002710) | 4.24210801 |
| 15 | negative thymic T cell selection (GO:0045060) | 4.21014224 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14969110 |
| 17 | regulation of B cell differentiation (GO:0045577) | 4.13759124 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 4.13196531 |
| 19 | interferon-gamma production (GO:0032609) | 4.10770099 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.04156278 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.04156278 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.04156278 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 4.04156278 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 4.04156278 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.04156278 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.95571471 |
| 27 | positive T cell selection (GO:0043368) | 3.95041465 |
| 28 | leukocyte aggregation (GO:0070486) | 3.94550609 |
| 29 | cellular extravasation (GO:0045123) | 3.91298028 |
| 30 | detection of other organism (GO:0098543) | 3.82854388 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 3.79619519 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.78546288 |
| 33 | response to interleukin-15 (GO:0070672) | 3.76216337 |
| 34 | detection of bacterium (GO:0016045) | 3.75871421 |
| 35 | T cell selection (GO:0045058) | 3.75757060 |
| 36 | thymic T cell selection (GO:0045061) | 3.70747596 |
| 37 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.65686032 |
| 38 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.64383858 |
| 39 | negative regulation of phagocytosis (GO:0050765) | 3.64370357 |
| 40 | regulation of T cell tolerance induction (GO:0002664) | 3.60375665 |
| 41 | T cell homeostasis (GO:0043029) | 3.58092721 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 3.57212477 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.52581369 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 3.48572658 |
| 45 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.46845946 |
| 46 | regulation of tolerance induction (GO:0002643) | 3.43126168 |
| 47 | tolerance induction (GO:0002507) | 3.43105122 |
| 48 | DNA unwinding involved in DNA replication (GO:0006268) | 3.41953228 |
| 49 | viral transcription (GO:0019083) | 3.39832389 |
| 50 | T cell migration (GO:0072678) | 3.37813700 |
| 51 | T cell receptor signaling pathway (GO:0050852) | 3.32176181 |
| 52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.27122038 |
| 53 | response to peptidoglycan (GO:0032494) | 3.26229875 |
| 54 | lymphocyte homeostasis (GO:0002260) | 3.23369846 |
| 55 | translational termination (GO:0006415) | 3.22480407 |
| 56 | mature B cell differentiation (GO:0002335) | 3.22098250 |
| 57 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.21621814 |
| 58 | response to muramyl dipeptide (GO:0032495) | 3.20893018 |
| 59 | myeloid cell activation involved in immune response (GO:0002275) | 3.20415164 |
| 60 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.16212791 |
| 61 | cellular response to interleukin-15 (GO:0071350) | 3.16204265 |
| 62 | V(D)J recombination (GO:0033151) | 3.16159643 |
| 63 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.16014996 |
| 64 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.16014996 |
| 65 | regulation of histone H3-K9 methylation (GO:0051570) | 3.15012448 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.14885283 |
| 67 | positive regulation of tolerance induction (GO:0002645) | 3.14812035 |
| 68 | negative regulation of histone methylation (GO:0031061) | 3.14146836 |
| 69 | mast cell activation (GO:0045576) | 3.13524301 |
| 70 | cellular response to type I interferon (GO:0071357) | 3.10830559 |
| 71 | type I interferon signaling pathway (GO:0060337) | 3.10830559 |
| 72 | response to type I interferon (GO:0034340) | 3.10360029 |
| 73 | positive regulation of isotype switching (GO:0045830) | 3.09060930 |
| 74 | neutrophil activation (GO:0042119) | 3.06977933 |
| 75 | detection of external biotic stimulus (GO:0098581) | 3.06326092 |
| 76 | T cell costimulation (GO:0031295) | 3.06096407 |
| 77 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.05558490 |
| 78 | positive regulation of interleukin-2 production (GO:0032743) | 3.05173095 |
| 79 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.03942423 |
| 80 | defense response to protozoan (GO:0042832) | 3.00909062 |
| 81 | respiratory burst (GO:0045730) | 3.00885729 |
| 82 | lymphocyte costimulation (GO:0031294) | 3.00248916 |
| 83 | response to protozoan (GO:0001562) | 2.99905620 |
| 84 | microglial cell activation (GO:0001774) | 2.99346149 |
| 85 | response to host immune response (GO:0052572) | 2.97312234 |
| 86 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.97312234 |
| 87 | ribosomal small subunit biogenesis (GO:0042274) | 2.96323675 |
| 88 | * natural killer cell differentiation (GO:0001779) | 2.95901019 |
| 89 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.95725604 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.95725604 |
| 91 | * positive regulation of granulocyte differentiation (GO:0030854) | 2.95654228 |
| 92 | leukocyte degranulation (GO:0043299) | 2.95314235 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.94346288 |
| 94 | germinal center formation (GO:0002467) | 2.93310514 |
| 95 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.92501594 |
| 96 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.90749371 |
| 97 | myeloid dendritic cell activation (GO:0001773) | 2.89537041 |
| 98 | negative regulation of adaptive immune response (GO:0002820) | 2.89274394 |
| 99 | leukocyte homeostasis (GO:0001776) | 2.89224612 |
| 100 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.87901070 |
| 101 | positive regulation of histone deacetylation (GO:0031065) | 2.87384260 |
| 102 | negative regulation of RNA splicing (GO:0033119) | 2.85381691 |
| 103 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84985868 |
| 104 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84262871 |
| 105 | alpha-beta T cell differentiation (GO:0046632) | 2.81558580 |
| 106 | translational elongation (GO:0006414) | 2.81070321 |
| 107 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.80295105 |
| 108 | alpha-beta T cell activation (GO:0046631) | 2.79906833 |
| 109 | definitive hemopoiesis (GO:0060216) | 2.78704787 |
| 110 | activated T cell proliferation (GO:0050798) | 2.77947079 |
| 111 | * regulation of alpha-beta T cell activation (GO:0046634) | 2.77542364 |
| 112 | response to host defenses (GO:0052200) | 2.76934719 |
| 113 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.76308594 |
| 114 | * mucosal-associated lymphoid tissue development (GO:0048537) | 2.75249801 |
| 115 | Peyers patch development (GO:0048541) | 2.75249801 |
| 116 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.74761131 |
| 117 | B cell homeostasis (GO:0001782) | 2.74440282 |
| 118 | vagina development (GO:0060068) | 2.73756686 |
| 119 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.73059356 |
| 120 | T cell proliferation (GO:0042098) | 2.72977055 |
| 121 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.71497202 |
| 122 | megakaryocyte development (GO:0035855) | 2.70791366 |
| 123 | B cell proliferation (GO:0042100) | 2.68731013 |
| 124 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.68112806 |
| 125 | NIK/NF-kappaB signaling (GO:0038061) | 2.67839956 |
| 126 | mature B cell differentiation involved in immune response (GO:0002313) | 2.67476036 |
| 127 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.66081298 |
| 128 | positive regulation of immunoglobulin production (GO:0002639) | 2.65890427 |
| 129 | immunoglobulin mediated immune response (GO:0016064) | 2.65777059 |
| 130 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.64772430 |
| 131 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.64587242 |
| 132 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.64034246 |
| 133 | mast cell activation involved in immune response (GO:0002279) | 2.63783121 |
| 134 | mast cell degranulation (GO:0043303) | 2.63783121 |
| 135 | mononuclear cell proliferation (GO:0032943) | 2.63569828 |
| 136 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.63464765 |
| 137 | positive regulation of B cell activation (GO:0050871) | 2.62515434 |
| 138 | DNA strand elongation (GO:0022616) | 2.60300886 |
| 139 | lymphocyte proliferation (GO:0046651) | 2.59507082 |
| 140 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.59201016 |
| 141 | negative regulation of B cell proliferation (GO:0030889) | 2.58874549 |
| 142 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.58440539 |
| 143 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.58061542 |
| 144 | * natural killer cell activation (GO:0030101) | 2.57744295 |
| 145 | hepatocyte apoptotic process (GO:0097284) | 2.57435690 |
| 146 | cellular response to zinc ion (GO:0071294) | 2.56167686 |
| 147 | regulation of regulatory T cell differentiation (GO:0045589) | 2.53905210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.45725771 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.08089939 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 4.06431581 |
| 4 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.66955130 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.60320771 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.55488011 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.14745496 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.12030268 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.08271719 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.02700894 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.92424933 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.81601636 |
| 13 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.60444468 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.53100569 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.48699680 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.41473421 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.38179776 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.37695683 |
| 19 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.29188277 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.27996159 |
| 21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.27807297 |
| 22 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.24324853 |
| 23 | * MYB_26560356_Chip-Seq_TH1_Human | 2.23208892 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22454286 |
| 25 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22410880 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.17721422 |
| 27 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.13008297 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10715308 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.10398780 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.98431774 |
| 31 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96208708 |
| 32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.96159774 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94425124 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92451189 |
| 35 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90876005 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90253288 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.90152838 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.86018555 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81746882 |
| 40 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.79585547 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78193969 |
| 42 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.74218867 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73408504 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.71412817 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.62700467 |
| 46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.60568781 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60070570 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58547068 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54157026 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54076460 |
| 51 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53343114 |
| 52 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.50714575 |
| 53 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.49943070 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43890397 |
| 55 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.42854372 |
| 56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41853260 |
| 57 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39902192 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39773179 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39456516 |
| 60 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.39449948 |
| 61 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39058995 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37765650 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34833187 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34627810 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33653967 |
| 66 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32542054 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29599925 |
| 68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.29051923 |
| 69 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.28829280 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28572893 |
| 71 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.27293997 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27197935 |
| 73 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.25471131 |
| 74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25088596 |
| 75 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.21402546 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20413083 |
| 77 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.18031502 |
| 78 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14552112 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13116484 |
| 80 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13030550 |
| 81 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.12229150 |
| 82 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11347455 |
| 83 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09835335 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08967773 |
| 85 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.06333706 |
| 86 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03495079 |
| 87 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01816594 |
| 88 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00489098 |
| 89 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00487653 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99755334 |
| 91 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.98661715 |
| 92 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.97311103 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97203717 |
| 94 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.96738391 |
| 95 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95805287 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94688256 |
| 97 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94302458 |
| 98 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94081402 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93191334 |
| 100 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93002421 |
| 101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92700780 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91455384 |
| 103 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89412948 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88699374 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88310485 |
| 106 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86353566 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86281882 |
| 108 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85941692 |
| 109 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85333323 |
| 110 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83063508 |
| 111 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.81762686 |
| 112 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.81626113 |
| 113 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79736290 |
| 114 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.79517083 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78010856 |
| 116 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76707956 |
| 117 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76341056 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76338907 |
| 119 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75499981 |
| 120 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.75277300 |
| 121 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73260505 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72084685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003763_abnormal_thymus_physiology | 3.76157744 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.58262171 |
| 3 | * MP0001800_abnormal_humoral_immune | 3.30181547 |
| 4 | MP0000685_abnormal_immune_system | 3.29421242 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.24855088 |
| 6 | MP0005671_abnormal_response_to | 3.16112839 |
| 7 | * MP0002398_abnormal_bone_marrow | 2.79642947 |
| 8 | MP0001790_abnormal_immune_system | 2.70717585 |
| 9 | MP0005387_immune_system_phenotype | 2.70717585 |
| 10 | MP0003303_peritoneal_inflammation | 2.69727792 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.68319814 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.66571409 |
| 13 | * MP0002723_abnormal_immune_serum | 2.57448745 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.54913411 |
| 15 | * MP0002420_abnormal_adaptive_immunity | 2.53807935 |
| 16 | * MP0001819_abnormal_immune_cell | 2.50000528 |
| 17 | MP0003436_decreased_susceptibility_to | 2.47095303 |
| 18 | * MP0000716_abnormal_immune_system | 2.33831382 |
| 19 | * MP0000689_abnormal_spleen_morphology | 2.32221020 |
| 20 | MP0004808_abnormal_hematopoietic_stem | 2.31024465 |
| 21 | MP0010307_abnormal_tumor_latency | 2.30042933 |
| 22 | * MP0002722_abnormal_immune_system | 2.28845387 |
| 23 | * MP0000703_abnormal_thymus_morphology | 2.27882879 |
| 24 | MP0001873_stomach_inflammation | 2.23784838 |
| 25 | MP0009785_altered_susceptibility_to | 2.22937467 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.21365962 |
| 27 | * MP0005025_abnormal_response_to | 2.20588606 |
| 28 | MP0002166_altered_tumor_susceptibility | 2.19528769 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 2.19095551 |
| 30 | * MP0002405_respiratory_system_inflammati | 2.01530538 |
| 31 | * MP0002429_abnormal_blood_cell | 2.00123895 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.98947894 |
| 33 | MP0002419_abnormal_innate_immunity | 1.96377693 |
| 34 | MP0004381_abnormal_hair_follicle | 1.95385748 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.86902322 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.86902322 |
| 37 | MP0010094_abnormal_chromosome_stability | 1.86629608 |
| 38 | MP0008057_abnormal_DNA_replication | 1.84597904 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.84106563 |
| 40 | MP0009278_abnormal_bone_marrow | 1.75674828 |
| 41 | MP0002006_tumorigenesis | 1.73113970 |
| 42 | MP0004947_skin_inflammation | 1.69559172 |
| 43 | MP0008995_early_reproductive_senescence | 1.68564914 |
| 44 | MP0001853_heart_inflammation | 1.64776119 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.62834022 |
| 46 | MP0002009_preneoplasia | 1.62005928 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.58061256 |
| 48 | MP0008260_abnormal_autophagy | 1.53486220 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.52408363 |
| 50 | MP0006082_CNS_inflammation | 1.46521496 |
| 51 | MP0000490_abnormal_crypts_of | 1.45741531 |
| 52 | MP0003693_abnormal_embryo_hatching | 1.43959016 |
| 53 | MP0003077_abnormal_cell_cycle | 1.43463700 |
| 54 | MP0003866_abnormal_defecation | 1.40646786 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.37253325 |
| 56 | MP0003111_abnormal_nucleus_morphology | 1.35434969 |
| 57 | MP0002933_joint_inflammation | 1.34420088 |
| 58 | MP0003724_increased_susceptibility_to | 1.33865468 |
| 59 | * MP0002019_abnormal_tumor_incidence | 1.32914288 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.30682852 |
| 61 | MP0004957_abnormal_blastocyst_morpholog | 1.17255769 |
| 62 | MP0003828_pulmonary_edema | 1.14344746 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.11909990 |
| 64 | MP0005451_abnormal_body_composition | 1.11617575 |
| 65 | MP0008469_abnormal_protein_level | 1.09816197 |
| 66 | MP0000858_altered_metastatic_potential | 1.02360903 |
| 67 | MP0009764_decreased_sensitivity_to | 1.01677674 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 0.99212750 |
| 69 | MP0004510_myositis | 0.98585568 |
| 70 | MP0005310_abnormal_salivary_gland | 0.98153748 |
| 71 | MP0003786_premature_aging | 0.96290223 |
| 72 | MP0008007_abnormal_cellular_replicative | 0.96133799 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 0.95897107 |
| 74 | MP0008961_abnormal_basal_metabolism | 0.93226730 |
| 75 | MP0006054_spinal_hemorrhage | 0.90510733 |
| 76 | MP0003448_altered_tumor_morphology | 0.85871070 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.83512698 |
| 78 | MP0001727_abnormal_embryo_implantation | 0.80093086 |
| 79 | MP0008058_abnormal_DNA_repair | 0.80021677 |
| 80 | MP0005076_abnormal_cell_differentiation | 0.79561348 |
| 81 | MP0000350_abnormal_cell_proliferation | 0.78979901 |
| 82 | MP0000313_abnormal_cell_death | 0.76433400 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.76083356 |
| 84 | MP0000569_abnormal_digit_pigmentation | 0.74208992 |
| 85 | MP0003690_abnormal_glial_cell | 0.74074097 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.72726830 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.72500777 |
| 88 | MP0002095_abnormal_skin_pigmentation | 0.71657620 |
| 89 | MP0005166_decreased_susceptibility_to | 0.71193427 |
| 90 | MP0003191_abnormal_cellular_cholesterol | 0.70932668 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 0.69259774 |
| 92 | MP0003045_fibrosis | 0.68596846 |
| 93 | MP0004130_abnormal_muscle_cell | 0.68594798 |
| 94 | MP0001851_eye_inflammation | 0.68352090 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.65682393 |
| 96 | MP0004883_abnormal_blood_vessel | 0.64714129 |
| 97 | MP0002736_abnormal_nociception_after | 0.64202304 |
| 98 | MP0001730_embryonic_growth_arrest | 0.64024373 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.62470850 |
| 100 | MP0000604_amyloidosis | 0.61421361 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.60471731 |
| 102 | MP0005164_abnormal_response_to | 0.60098445 |
| 103 | MP0001919_abnormal_reproductive_system | 0.58561765 |
| 104 | * MP0001663_abnormal_digestive_system | 0.58398458 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.57790771 |
| 106 | MP0002970_abnormal_white_adipose | 0.57633096 |
| 107 | MP0005058_abnormal_lysosome_morphology | 0.56412046 |
| 108 | MP0009672_abnormal_birth_weight | 0.55799300 |
| 109 | MP0000609_abnormal_liver_physiology | 0.55361513 |
| 110 | MP0000477_abnormal_intestine_morphology | 0.55353189 |
| 111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54831582 |
| 112 | MP0003795_abnormal_bone_structure | 0.53167983 |
| 113 | MP0003091_abnormal_cell_migration | 0.52911223 |
| 114 | MP0002132_abnormal_respiratory_system | 0.52770064 |
| 115 | MP0000249_abnormal_blood_vessel | 0.52060942 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.51984348 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.50942932 |
| 118 | MP0003787_abnormal_imprinting | 0.50826032 |
| 119 | MP0005646_abnormal_pituitary_gland | 0.50686505 |
| 120 | MP0009763_increased_sensitivity_to | 0.50535324 |
| 121 | MP0001915_intracranial_hemorrhage | 0.50148370 |
| 122 | MP0005390_skeleton_phenotype | 0.49352030 |
| 123 | MP0008874_decreased_physiological_sensi | 0.49333591 |
| 124 | MP0003075_altered_response_to | 0.48927691 |
| 125 | MP0009115_abnormal_fat_cell | 0.46711602 |
| 126 | MP0002693_abnormal_pancreas_physiology | 0.46491274 |
| 127 | MP0005621_abnormal_cell_physiology | 0.42267969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgM deficiency (HP:0002850) | 5.64934750 |
| 2 | Recurrent viral infections (HP:0004429) | 5.02275229 |
| 3 | Thyroiditis (HP:0100646) | 4.55058092 |
| 4 | T lymphocytopenia (HP:0005403) | 4.53811958 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 4.53761855 |
| 6 | Agammaglobulinemia (HP:0004432) | 4.41623854 |
| 7 | Abnormality of T cell number (HP:0011839) | 4.32533728 |
| 8 | Cellulitis (HP:0100658) | 4.30247853 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.25313420 |
| 10 | Recurrent bronchitis (HP:0002837) | 4.23524799 |
| 11 | B lymphocytopenia (HP:0010976) | 4.12739506 |
| 12 | Abnormality of B cell number (HP:0010975) | 4.12739506 |
| 13 | Abnormality of T cells (HP:0002843) | 3.94092430 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.91739879 |
| 15 | Chronic otitis media (HP:0000389) | 3.90014489 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.88640749 |
| 17 | Optic neuritis (HP:0100653) | 3.88640749 |
| 18 | Abnormality of the fingertips (HP:0001211) | 3.83364781 |
| 19 | Meningitis (HP:0001287) | 3.82717077 |
| 20 | Orchitis (HP:0100796) | 3.82444014 |
| 21 | Gastrointestinal inflammation (HP:0004386) | 3.81775024 |
| 22 | Verrucae (HP:0200043) | 3.79816153 |
| 23 | Papilloma (HP:0012740) | 3.79816153 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.78816285 |
| 25 | Inflammation of the large intestine (HP:0002037) | 3.78378875 |
| 26 | Severe combined immunodeficiency (HP:0004430) | 3.75618804 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.56365523 |
| 28 | Combined immunodeficiency (HP:0005387) | 3.54850130 |
| 29 | Colitis (HP:0002583) | 3.53664693 |
| 30 | Thrombocytosis (HP:0001894) | 3.52353515 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.50488486 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.43312560 |
| 33 | Abnormality of T cell physiology (HP:0011840) | 3.30812871 |
| 34 | Recurrent bacterial skin infections (HP:0005406) | 3.25771476 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 3.23227133 |
| 36 | IgG deficiency (HP:0004315) | 3.17737508 |
| 37 | Lymphopenia (HP:0001888) | 3.15966038 |
| 38 | Reticulocytopenia (HP:0001896) | 3.14995267 |
| 39 | IgA deficiency (HP:0002720) | 3.13835257 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 3.12648582 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.12648582 |
| 42 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.07336341 |
| 43 | Eosinophilia (HP:0001880) | 3.02641415 |
| 44 | Myositis (HP:0100614) | 3.01611290 |
| 45 | Keratoconjunctivitis sicca (HP:0001097) | 2.99352646 |
| 46 | Nasal polyposis (HP:0100582) | 2.96521340 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.95110760 |
| 48 | Abnormal number of erythroid precursors (HP:0012131) | 2.89593620 |
| 49 | Vasculitis (HP:0002633) | 2.86993248 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.85500636 |
| 51 | Keratoconjunctivitis (HP:0001096) | 2.84740266 |
| 52 | Granulocytopenia (HP:0001913) | 2.79554760 |
| 53 | Gingivitis (HP:0000230) | 2.78451186 |
| 54 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.77362127 |
| 55 | Increased IgM level (HP:0003496) | 2.75816873 |
| 56 | Recurrent skin infections (HP:0001581) | 2.74370294 |
| 57 | Recurrent sinusitis (HP:0011108) | 2.74352554 |
| 58 | Lymphoma (HP:0002665) | 2.74271622 |
| 59 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.73764443 |
| 60 | Obstructive lung disease (HP:0006536) | 2.73600489 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73600489 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.73009514 |
| 63 | Abnormality of eosinophils (HP:0001879) | 2.72530891 |
| 64 | Gastrointestinal stroma tumor (HP:0100723) | 2.68377671 |
| 65 | Hypoplasia of the thymus (HP:0000778) | 2.67459642 |
| 66 | Urticaria (HP:0001025) | 2.63604362 |
| 67 | Pustule (HP:0200039) | 2.63013945 |
| 68 | Leukocytosis (HP:0001974) | 2.59586398 |
| 69 | Interstitial pulmonary disease (HP:0006530) | 2.54945581 |
| 70 | Osteomyelitis (HP:0002754) | 2.52988596 |
| 71 | Petechiae (HP:0000967) | 2.51748774 |
| 72 | Abnormality of the nasal mucosa (HP:0000433) | 2.51190278 |
| 73 | Increased IgE level (HP:0003212) | 2.49560497 |
| 74 | Stomatitis (HP:0010280) | 2.43771915 |
| 75 | Chronic sinusitis (HP:0011109) | 2.39214088 |
| 76 | Sepsis (HP:0100806) | 2.38188323 |
| 77 | Pulmonary embolism (HP:0002204) | 2.37087151 |
| 78 | Chest pain (HP:0100749) | 2.36867155 |
| 79 | Viral hepatitis (HP:0006562) | 2.36353186 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.33218543 |
| 81 | Fatigue (HP:0012378) | 2.32730358 |
| 82 | Slow saccadic eye movements (HP:0000514) | 2.32117990 |
| 83 | Papilledema (HP:0001085) | 2.28489422 |
| 84 | Arterial thrombosis (HP:0004420) | 2.28059553 |
| 85 | Encephalitis (HP:0002383) | 2.27877157 |
| 86 | Epistaxis (HP:0000421) | 2.26763671 |
| 87 | Microcytic anemia (HP:0001935) | 2.25930689 |
| 88 | Bronchitis (HP:0012387) | 2.24683144 |
| 89 | Basal cell carcinoma (HP:0002671) | 2.21096040 |
| 90 | Hypergammaglobulinemia (HP:0010702) | 2.20394216 |
| 91 | Abnormal platelet volume (HP:0011876) | 2.19377991 |
| 92 | Chronic diarrhea (HP:0002028) | 2.16390818 |
| 93 | Anorexia (HP:0002039) | 2.15452122 |
| 94 | Impaired platelet aggregation (HP:0003540) | 2.12797514 |
| 95 | Abnormal platelet function (HP:0011869) | 2.12797514 |
| 96 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.12349005 |
| 97 | Amaurosis fugax (HP:0100576) | 2.10211814 |
| 98 | Pallor (HP:0000980) | 2.09511816 |
| 99 | Abnormality of the pleura (HP:0002103) | 2.07903463 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 2.05563090 |
| 101 | Periodontitis (HP:0000704) | 2.04358768 |
| 102 | Acute hepatic failure (HP:0006554) | 2.04228850 |
| 103 | Hypochromic anemia (HP:0001931) | 2.02926218 |
| 104 | Skin ulcer (HP:0200042) | 2.00131625 |
| 105 | Emphysema (HP:0002097) | 1.99884430 |
| 106 | Gangrene (HP:0100758) | 1.99810024 |
| 107 | Recurrent lower respiratory tract infections (HP:0002783) | 1.99046629 |
| 108 | Gingival bleeding (HP:0000225) | 1.98534230 |
| 109 | Joint swelling (HP:0001386) | 1.98027121 |
| 110 | Increased density of long bones (HP:0006392) | 1.96677022 |
| 111 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.96213778 |
| 112 | Acute lymphatic leukemia (HP:0006721) | 1.95921469 |
| 113 | Pulmonary infiltrates (HP:0002113) | 1.92746100 |
| 114 | Acute myeloid leukemia (HP:0004808) | 1.92155775 |
| 115 | Recurrent pneumonia (HP:0006532) | 1.91487338 |
| 116 | Recurrent otitis media (HP:0000403) | 1.91153663 |
| 117 | Skin rash (HP:0000988) | 1.90631522 |
| 118 | Prominent nose (HP:0000448) | 1.90441450 |
| 119 | Volvulus (HP:0002580) | 1.88603578 |
| 120 | Abnormality of the prostate (HP:0008775) | 1.87168340 |
| 121 | Gastrointestinal infarctions (HP:0005244) | 1.85405286 |
| 122 | Hemoptysis (HP:0002105) | 1.85271898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.41234705 |
| 2 | EEF2K | 3.36785212 |
| 3 | PRPF4B | 3.23383622 |
| 4 | MAP3K10 | 3.00782063 |
| 5 | IKBKE | 2.90926022 |
| 6 | TXK | 2.51539422 |
| 7 | STK10 | 2.50715907 |
| 8 | ERN1 | 2.41787964 |
| 9 | ZAP70 | 2.18326684 |
| 10 | * BTK | 2.15028090 |
| 11 | GRK6 | 2.14764799 |
| 12 | JAK3 | 2.08900930 |
| 13 | PKN2 | 2.06597001 |
| 14 | * SYK | 1.93507661 |
| 15 | CSF1R | 1.89458688 |
| 16 | TYK2 | 1.85164346 |
| 17 | CDC7 | 1.79654095 |
| 18 | TRIB3 | 1.74918792 |
| 19 | ITK | 1.70657832 |
| 20 | LRRK2 | 1.62218737 |
| 21 | BLK | 1.62190943 |
| 22 | LCK | 1.56383060 |
| 23 | CDK12 | 1.46582173 |
| 24 | CDK4 | 1.42715206 |
| 25 | CLK1 | 1.41250516 |
| 26 | SIK2 | 1.40716100 |
| 27 | TEC | 1.39337191 |
| 28 | HCK | 1.38141705 |
| 29 | TBK1 | 1.35838399 |
| 30 | KIT | 1.35651501 |
| 31 | TNK2 | 1.34274364 |
| 32 | FES | 1.31666407 |
| 33 | PIM1 | 1.24682199 |
| 34 | MAP3K14 | 1.19043068 |
| 35 | CHUK | 1.19020549 |
| 36 | CSK | 1.15511093 |
| 37 | BMPR2 | 1.13221698 |
| 38 | FGFR3 | 1.12732956 |
| 39 | MAPK4 | 1.10426813 |
| 40 | FLT3 | 1.08797856 |
| 41 | RPS6KA2 | 1.08038447 |
| 42 | IRAK4 | 1.07868658 |
| 43 | LYN | 1.06171686 |
| 44 | PIK3CG | 1.04742989 |
| 45 | JAK1 | 1.03885488 |
| 46 | CAMKK2 | 1.03744746 |
| 47 | SCYL2 | 1.02355928 |
| 48 | CDK7 | 1.00132260 |
| 49 | SMG1 | 0.99390515 |
| 50 | NEK2 | 0.98915933 |
| 51 | STK4 | 0.98365392 |
| 52 | FGR | 0.97870976 |
| 53 | RPS6KA6 | 0.97640133 |
| 54 | RPS6KC1 | 0.96459900 |
| 55 | RPS6KL1 | 0.96459900 |
| 56 | MAP3K1 | 0.92140384 |
| 57 | IKBKB | 0.91194249 |
| 58 | RIPK4 | 0.88709946 |
| 59 | CAMKK1 | 0.87314094 |
| 60 | FGFR4 | 0.86920847 |
| 61 | MAP2K3 | 0.84775764 |
| 62 | MAP3K3 | 0.84489876 |
| 63 | RPS6KB2 | 0.84191279 |
| 64 | ALK | 0.81636032 |
| 65 | RPS6KA4 | 0.80630343 |
| 66 | TGFBR2 | 0.79648702 |
| 67 | MAP3K11 | 0.79117606 |
| 68 | CDK6 | 0.75389651 |
| 69 | MAPKAPK2 | 0.74677938 |
| 70 | HIPK2 | 0.73237872 |
| 71 | MARK3 | 0.73231381 |
| 72 | MAP3K7 | 0.73002254 |
| 73 | NLK | 0.72764133 |
| 74 | RPS6KB1 | 0.70060362 |
| 75 | ATR | 0.70051230 |
| 76 | EPHB1 | 0.69911787 |
| 77 | KSR2 | 0.69673379 |
| 78 | MAP3K8 | 0.68959665 |
| 79 | MAPK7 | 0.68674378 |
| 80 | PIM2 | 0.68575525 |
| 81 | MAPK11 | 0.66881073 |
| 82 | YES1 | 0.66013088 |
| 83 | IRAK1 | 0.65916299 |
| 84 | JAK2 | 0.64558519 |
| 85 | MAP3K13 | 0.63861178 |
| 86 | TAOK3 | 0.61860828 |
| 87 | KDR | 0.59916460 |
| 88 | BRD4 | 0.56454948 |
| 89 | PRKCQ | 0.55976807 |
| 90 | MST4 | 0.54967057 |
| 91 | TAOK2 | 0.54374870 |
| 92 | SGK3 | 0.53558158 |
| 93 | PTK6 | 0.51328689 |
| 94 | TESK2 | 0.51114358 |
| 95 | FYN | 0.50494795 |
| 96 | SGK2 | 0.50184927 |
| 97 | PRKCH | 0.50132417 |
| 98 | SIK1 | 0.49812213 |
| 99 | TRPM7 | 0.47625995 |
| 100 | MATK | 0.47345759 |
| 101 | MAPK12 | 0.46712813 |
| 102 | PDK1 | 0.45753947 |
| 103 | EIF2AK1 | 0.45526903 |
| 104 | MAP3K2 | 0.44947083 |
| 105 | PASK | 0.44591879 |
| 106 | WNK1 | 0.43899243 |
| 107 | CDK9 | 0.42535250 |
| 108 | ABL1 | 0.42481604 |
| 109 | TAOK1 | 0.42172153 |
| 110 | MELK | 0.41451611 |
| 111 | RET | 0.39705352 |
| 112 | CDC42BPA | 0.39701999 |
| 113 | SIK3 | 0.39626031 |
| 114 | PDPK1 | 0.39036268 |
| 115 | RPS6KA1 | 0.38735306 |
| 116 | CHEK1 | 0.38172868 |
| 117 | EIF2AK3 | 0.37450230 |
| 118 | CAMK4 | 0.36847098 |
| 119 | IRAK2 | 0.35877817 |
| 120 | MAP2K2 | 0.34700161 |
| 121 | NME2 | 0.34619447 |
| 122 | STK11 | 0.32245038 |
| 123 | AKT2 | 0.32044314 |
| 124 | RAF1 | 0.31326411 |
| 125 | MAPK3 | 0.31065750 |
| 126 | CDK2 | 0.30262979 |
| 127 | PRKD2 | 0.29829666 |
| 128 | MAP3K5 | 0.29647840 |
| 129 | TLK1 | 0.28509277 |
| 130 | BUB1 | 0.26840739 |
| 131 | MARK2 | 0.26667859 |
| 132 | TGFBR1 | 0.26640855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.54497824 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.12229842 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.88753772 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35088268 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.30829635 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.21829928 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.21520807 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.20415364 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.20222353 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.15752444 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.14888974 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00875734 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 1.96965467 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95378167 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 1.91533861 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.90805200 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.89717382 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.79294128 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.70963089 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.68097068 |
| 21 | Spliceosome_Homo sapiens_hsa03040 | 1.61991950 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.58788855 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.51656960 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.46650401 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46305037 |
| 26 | Hepatitis B_Homo sapiens_hsa05161 | 1.43480437 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37371197 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34487811 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33806311 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.32945225 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32139534 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29652593 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.25292635 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.24759879 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22359776 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.21250033 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20699330 |
| 38 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.18330269 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17972077 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.17495225 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.16052294 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15907647 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14095464 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.13192556 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.13133791 |
| 46 | HTLV-I infection_Homo sapiens_hsa05166 | 1.10737922 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10162389 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.06321698 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03035682 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.02414292 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 1.00340845 |
| 52 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.95772081 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93076042 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92587871 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.88334589 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87936449 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85555390 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85312907 |
| 59 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.85304683 |
| 60 | RNA transport_Homo sapiens_hsa03013 | 0.84168808 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84133955 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83966150 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.83232300 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82692735 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81896608 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76392607 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75414565 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.75044237 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.73375221 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.72785422 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.71920698 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71052787 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70482228 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.70073673 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69849716 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69785586 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69257985 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67796720 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.66061040 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.65908379 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65234241 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64490073 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63490949 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62974564 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61576350 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.60278644 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59190742 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59019874 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58736449 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58443373 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.58185491 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56314455 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54537251 |
| 94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53902646 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52863052 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.51163114 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51088840 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49583648 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46500238 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46109671 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45178016 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45037634 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42767330 |
| 104 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.42132398 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41964612 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.40511432 |
| 107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40385063 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.40253173 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39403642 |
| 110 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38387478 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38285633 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38253009 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.38105747 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37954198 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37359480 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36916446 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36905515 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31783681 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31411616 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30100770 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30065635 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29437659 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28387160 |
| 124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27802247 |
| 125 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27312478 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26273452 |

